SCHEMBL7751508

SCHEMBL7751508

C=C(c1ncccc1[N+](=O)[O-])N(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.45
ALDH1A1 P00352 5/20 0.44
POLB P06746 1/20 0.44
PAX8 Q06710 1/20 0.41
MEN1 O00255 5/20 0.41
KMT2A Q03164 5/20 0.41
MAPT P10636 4/20 0.41
RAB9A P51151 3/20 0.41
NPC1 O15118 3/20 0.41
KDM4E B2RXH2 2/20 0.41
CTSB P07858 2/20 0.41
LMNA P02545 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HSP90AA1 P07900 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
GAA P10253 1/20 0.41
IDO1 P14902 1/20 0.41
TDO2 P48775 1/20 0.41
NCOA1 Q15788 1/20 0.41
NCOA3 Q9Y6Q9 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11724759 0.83 ALDH1A1 (0.48) PDE10AALDH1A1POLBPAX8MEN1
SCHEMBL29823981 0.82 PDE10A (0.49) PDE10AALDH1A1POLBPAX8MEN1
SCHEMBL3381186 0.77 ALDH1A1 (0.51) PDE10AALDH1A1POLBPAX8MEN1
SCHEMBL305884 0.76 PDE10A (0.53) PDE10AALDH1A1POLBPAX8MEN1
SCHEMBL8566546 0.75 MEN1 (0.48) PDE10AALDH1A1POLBMEN1KMT2A
SCHEMBL828239 0.75 TDP1 (0.50) ALDH1A1KMT2AKDM4ESMN1; SMN2TDP1
SCHEMBL1232905 0.75 KDM4E (0.54) PDE10AALDH1A1POLBMEN1KMT2A
SCHEMBL3382130 0.75 RAB9A (0.50) PDE10AALDH1A1POLBPAX8MEN1
SCHEMBL29028896 0.74 ALDH1A1 (0.60) PDE10AALDH1A1POLBMEN1KMT2A
SCHEMBL6448689 0.73 PDE10A (0.50) PDE10AALDH1A1POLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1117733-C Process for synthesis of ribonucleotide reductase inhibitors 3-AP and 3-AMP VION PHARMACEUTICALS INC (US) 2003-08-13 CN disclosed
EP-0984932-A4 PROCESS FOR THE SYNTHESIS OF RIBONUCLEOTIDE REDUCTASE INHIBITORS 3-AP AND 3-AMP VION PHARMACEUTICALS INC (US) 2001-04-04 EP disclosed
CN-1256688-A Synthesis method of ribonucleotide reductase inhibitor 3-AP and 3AMP VION PHARMACEUTICALS INC (US) 2000-06-14 CN disclosed
EP-0984932-A1 PROCESS FOR THE SYNTHESIS OF RIBONUCLEOTIDE REDUCTASE INHIBITORS 3-AP AND 3-AMP Vion Pharmaceuticals, Inc. (US) 2000-03-15 EP disclosed
US-5869676-A Process for the synthesis of ribonucleotide reductase inhibitors 3-AP and 3-AMP VION PHARMACEUTICALS, INC. (US) 1999-02-09 US disclosed
WO-1998051670-A1 PROCESS FOR THE SYNTHESIS OF RIBONUCLEOTIDE REDUCTASE INHIBITORS 3-AP AND 3-AMP VION PHARMACEUTICALS, INC. (US) 1998-11-19 WO disclosed